摘要

<jats:sec id="S1481803514000360_abs1" sec-type="general"><jats:title>Clinical Question</jats:title><jats:p>Can an accelerated 2-hour diagnostic protocol using the cardiac troponin I (cTnI) measurement as the only biomarker be implemented to allow an earlier and safe discharge of low-risk chest pain patients?</jats:p></jats:sec><jats:sec id="S1481803514000360_abs2" sec-type="general"><jats:title>Article Chosen</jats:title><jats:p>Than M, Cullen L, Aldous S, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial.<jats:italic>J Am Coll Cardiol</jats:italic>2012;59(23):2091-8.</jats:p></jats:sec><jats:sec id="S1481803514000360_abs3" sec-type="general"><jats:title>Objective</jats:title><jats:p>To determine whether an accelerated diagnostic protocol (ADP) for possible cardiac chest pain could identify low-risk patients suitable for early discharge using cTnI as the sole biomarker.</jats:p></jats:sec>

  • 出版日期2015-7